Cardiac software debuts

Article

Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient

Amersham Health launched analytical software designed to help practitioners better identify, measure, and manage costs associated with myocardial perfusion imaging studies on Jan. 8. MPOptions models economic factors affecting office-based and outpatient imaging centers and provides what-if scenarios to explore alternatives for delivering nuclear cardiology services efficiently and cost-effectively. The software calculates costs in several categories, including labor, capital equipment, facility, pharmaceutical, and supplies. MPOptions was developed with Amersham funding by physicians at Cardiovascular Consultants in St. Louis and Georgetown University in Washington, DC.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.